ASF1B silencing inhibits the growth and cell cycle arrest, induces apoptosis, and reduces the expression levels of PCNA, cyclinB1, cyclinE2, and CDK9 in HCC cells (28). The gene discussed is CDK9; the disease is hepatocellular carcinoma.